World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
49330
World Ranking
12904
National Ranking
6596

Overview

Neal D. Shore is affiliated with the Carolina Urologic Research Center in the United States. Their research primarily contributes to the field of Medicine, with a focus on specialties including Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging, and Cancer Research.

The main topics covered in their body of work involve Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Cancer, Lipids, and Metabolism, PARP inhibition in cancer therapy, and Hormonal and reproductive studies.

Neal D. Shore has co-authored frequently with the following researchers:

  • Fred Saad
  • Karim Fizazi
  • Ugo De Giorgi
  • Arun Azad
  • Bertrand Tombal

They have published multiple papers in prominent venues, including:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • Annals of Oncology
  • Future Oncology
  • European Urology

Recent notable publications with corresponding years and venues are:

  • Olaparib for Metastatic Castration-Resistant Prostate Cancer (2020) in New England Journal of Medicine
  • Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer (2020) in New England Journal of Medicine
  • Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial (2023) in The Lancet
  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020) in New England Journal of Medicine
  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer (2020) in New England Journal of Medicine

Their scientific output reflects extensive work on prostate cancer therapies, with investigations into hormonal treatments, androgen-deprivation therapies, and targeted PARP inhibitor therapies.

Best Publications

  • Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

    Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

    Karim Fizazi;Michael Carducci;Matthew Smith;Ronaldo Damião

  • Olaparib for metastatic castration-resistant prostate cancer

    Johann de Bono;Joaquin Mateo;Karim Fizazi;Fred Saad

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer

    Maha Hussain;Karim Fizazi;Fred Saad;Per Rathenborg

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

    Andrew J. Armstrong;Russell Z. Szmulewitz;Daniel P. Petrylak;Jeffrey Holzbeierlein

  • Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

    F. Saad;J. E. Brown;C. Van Poznak;T. Ibrahim

  • Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

    Karim Fizazi;Neal Shore;Teuvo L. Tammela;Albertas Ulys

  • The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

    Laurence Klotz;Laurent Boccon-Gibod;Neal D. Shore;Cal Andreou

  • Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.

    Maha Hussain;Joaquin Mateo;Karim Fizazi;Fred Saad

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

    Dipen J. Parekh;Sanoj Punnen;Daniel D. Sjoberg;Scott W. Asroff

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

    Neal D. Shore;Fred Saad;Michael S. Cookson;Daniel J. George

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

    Cora N. Sternberg;Karim Fizazi;Fred Saad;Neal D. Shore

  • Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)

    Dana E. Rathkopf;Matthew R. Smith;Johann S. De Bono;Christopher J. Logothetis

  • Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

    Neal D Shore;Simon Chowdhury;Arnauld Villers;Laurence Klotz

Frequent Co-Authors

Karim Fizazi
Karim Fizazi University of Paris-Saclay
Fred Saad
Fred Saad University of Montreal
Matthew R. Smith
Matthew R. Smith Harvard University
E. David Crawford
E. David Crawford University of California, San Diego
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Celestia S. Higano
Celestia S. Higano University of Washington
Oliver Sartor
Oliver Sartor Tulane University
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Emmanuel S. Antonarakis
Emmanuel S. Antonarakis University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean becoming a physician. The U.S. offers a range of flexible online degrees and alternative pathways for students with different interests and backgrounds. These programs are ideal for career changers, working professionals, or those looking for a direct pathway into healthcare fields.

For instance, if you are interested in becoming a nurse but want to avoid lengthy, traditional admissions tests, consider a nursing school that does not require teas test. This option streamlines the admissions process, making nursing more accessible for many students.

If speed is important, look into accelerated healthcare programs that fast-track you into health administration or management roles. Nurses seeking career advancement can pursue an rn to np bridge program, allowing licensed RNs to become nurse practitioners with greater responsibility.

For those interested in preventive health or public education, there’s the option of a comprehensive nutrition bachelor degree online. This program provides a foundation for careers in wellness, dietetics, or community health.

These online degrees and career pathways offer alternative routes into healthcare—helping you find the best fit for your skills and passions within the field of medicine.

Best Scientists Citing Neal D. Shore

Trending Scientists